Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Funding awarded for research into zoonotic pig disease
Streptococcus suis can be transferred to humans who handle livestock.
Streptococcus suis can be fatal to pigs.

A group of scientists has received government funding to develop a vaccine to tackle the bacterial infection Streptococcus suis.

Streptococcus suis is a bacterial infection that can cause serious, and often fatal, disease in pigs. It can also be transferred to humans who handle infected livestock.

It is one of the more common diseases affecting the UK pig population, as well as affecting over 60 per cent of pig farms in countries across Europe.

There are currently no proven vaccines for tackling the various strains of the disease.

The UK government is aiming to achieve a 50 per cent reduction in antibiotic use in livestock by 2030. The goal forms part of a global drive to tackle the threat of antimicrobial resistance.

The Department of Environment, Food and Rural Affairs has now issued a £1m grant from its Farming Innovation Programme for the development of an effective vaccine against the disease.

The vaccine project is to be led by The Vaccine Group, the University of Plymouth and the University of Cambridge.

In previous research, the University of Cambridge and the University of Plymouth had identified a potential candidate for the Streptococcus suis vaccine. This vaccine would work by administering a harmless virus, which would generate a greater quantity of the proteins which induce an immune response.

The group will now investigate whether this existing vaccine candidate, which has been proven to be effective against a common strain of the disease, is also effective for use to protect pigs from multiple strains of the disease. By extension, this could prevent transmission to humans.

The research team will conduct trials in conjunction with animal health specialists from Moredun Scientific Ltd.

It will also engage directly with the pig farming community, ensuring the vaccine meets their requirements and can be administered in an efficient, cost-effective way.

Jeremy Salt, chief executive officer at The Vaccine Group, said: “As a zoonotic infection, there is also the risk of the disease being passed on to humans working in the industry.

“Our goal in developing an effective vaccine is stop the bacterial infection from developing in pigs and humans in the first place. By doing so, we can better protect the farmers, their animals and their livelihoods.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

BEVA gives RVNs right to vote

News Story 1
 The British Equine Veterinary Association (BEVA) is to allow its registered veterinary nurse (RVN) members the right to vote.

RVN members will now be able to take part in key decision-making processes and stand for BEVA council.

Marie Rippingale, chair of BEVA's Nurse Committee, said: "I am very proud to be a part of BEVA.

"This change will help to empower nurses to speak up and contribute, but more importantly, it will give them an opportunity to collaborate with other members of the equine veterinary profession to bring about change that is positive for all." 

Click here for more...
News Shorts
Farmer survey to reveal on-farm impact of bluetongue

A nationwide survey has been launched to better understand how the bluetongue virus is affecting UK farms.

Results will inform the support that farmers receive for bluetongue, as well as preparing the livestock industry for the future.

The short online survey is open to all livestock farmers, regardless of whether they've had a confirmed case of bluetongue on their farm. It asks how many animals have been affected, the severity of their clinical signs and how it has impacted farm business.

The survey takes five minutes to complete and is fully anonymous.

It is led by Fiona Lovatt, of Flock Health Limited, and the Ruminant Health & Welfare bluetongue working group, in collaboration with AHDB and the University of Nottingham.

Dr Lovatt says: "We need to find out what level of clinical signs farmers are seeing in their animals, whether they are experiencing mortality with BTV-3 cases, and what their appetite is to vaccinate in future for bluetongue serotype 3."

The survey can be found here.